Neuroendocrine effects of a 20-mg citalopram infusion in healthy males a placebo-controlled evaluation of citalopram as 5-HT function probe

Neuropsychopharmacology

Volumn 14, Issue 4, 1996, Pages 253-263

  Seifritz, Erich ^a,c,d   Baumann, Pierre ^b   Müller, Matthias J ^a   Annen, Oliver ^a   Amey, Marlyse ^b   Hemmeter, Ulrich ^a   Hatzinger, Martin ^a   Chardon, François ^a   Holsboer Trachsler, Edith ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

5 HT receptor probe; 5 Hydroxytryptamine; Cytochrome P 450; Enantioselectivity; Neuroendocrinology; Pharmacokinetics; Serotonin reuptake inhibitor; Side effects; SSRI

Indexed keywords

CITALOPRAM; DINORCITALOPRAM; GROWTH HORMONE; HYDROCORTISONE; NORCITALOPRAM; PLACEBO; PROLACTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG METABOLISM; ENANTIOMER; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE ENDING; NEUROENDOCRINOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECTUM TEMPERATURE; SEROTONINERGIC SYSTEM; SINGLE BLIND PROCEDURE; VOLUNTEER;

CITALOPRAM; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PROLACTIN; RECEPTORS, SEROTONIN; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 0029879868     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00117-V     Document Type: Article

References (76)

1. Anderson IM, Cowen PJ (1986): Clomipramine enhances prolactin and growth hormone responses to L-tryptophan. Psychopharmacology 89:131-133
2. Ansseau M, Lembreghts M, Pitchot W, Gonzalez-Moreno A, Legros JJ, Bradford LD (1992): Neuroendocrine responses to intravenous flesinoxan as an index of serotonergic neurotransmission. Clin Neuropharmacol 15:113B
3. Asnis GM, Wetzler S, Sanderson SC, Kahn RS, Van Praag HM (1992): Functional interrelationship of serotonin and norepinephrine: Cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiatr Res 43:65-76
4. Baumann P, Jonzier-Perey M (1988): GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin. Clin Chim Acta 171:211-222
5. Baumann P, Meyer JW, Amey M, Baettig D, Bryois C, Jonzier-Perey M, Koeb L, Monney C, Woggon B (1992): Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptyline. Ther Drug Monit 14:1-8
6. Benkelfat C (1993): Serotonergic mechanisms in psychiatric disorders: New research tools, new ideas. Int Clin Psychopharmacol 8(Suppl 2):53-56
7. Born J, Muth S, Fehm HL (1988): The significance of sleep onset and slow wave sleep for nocturnal release of growth hormone (GH) and cortisol. Psychoneuroendocrinology 13:233-243
8. Carlsson A, Corrodi H, Fuxe K, Hökfelt T (1969): Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol 5:367-373
9. Casaneuva FF, Villanueva L, Peñalva A, Cabaezas-Cerrato J (1984): Depending on the stimulus central serotonergic activation by fenfluramine blocks or does not alter growth hormone secretion in man. Neuroendocrinology 38:302-308
10. Charbonnier JF, Reboul P, Rougier M, Aubin B, Chassaing JL, Philippe P, Planche R, Hoepfner Petersen HF (1987): Etude ouverte d'un inhibiteur très sélectif du capatage de la sérotonine, administré en perfusion à des patients déprimés. Encéphale 13:249-254
11. Charig EM, Anderson IM, Robinson JM, Nutt DJ, Cowen PJ (1986): Tryptophan and prolactin release: Evidence for interaction between 5-HT1 and 5-HT2 receptors. Hum Psychopharm 1:93-97
12. Cleare AJ, Bond AJ (1995): The effect of tryptophan depletion and enhancement on subjective and behavioral aggression in normal male subjects. Psychopharmacology 118:72-81
13. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989): Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatr 46:587-599
14. Cowen PJ, Anderson IM (1986): 5-HT neuroendocrinology: Changes during depressive illness and antidepressant drug treatment. In Deakin JFW, Freeman H (eds), Recent Advances in the Biology of Depression, Royal College of Psychiatrists, London, Gaskel.
15. Cowen PJ, McCance SL, Cohen PR, Julier DL (1989): Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression. Psychopharmacology 99: 230-232
16. Cowen PJ, Anderson IM, Graham-Smith DG (1990): Neuroendocrine effects of azapirones. J Clin Psychopharmacol 10(Suppl 3):21S-25S
17. Delgado PL, Price LH, Miller HL, Salomon RM, Licinio J, Krystal JH, Heninger GR, Charney DS (1991): Rapid serotonin depletion as a provocative challenge test for patients with major depression: Relevance to antidepressant action and the neurobiology of depression. Psychopharm Bull 27:321-330
18. Fessler RG, Deyo SN, Meltzer HY, Miller RJ (1984): Evidence that the medial and dorsal raphe nuclei mediate serotonergically-induced increases in prolactin release from the pituitary. Brain Res 299:231-237
19. 1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls. Neuropsychopharmacology (in press)
20. Golden RN, Ekstrom D, Brown TM, Ruegg R, Evans DL, Haggerty JJ, Garbutt JC, Pedersen CA, Mason GA, Browne J, Carson SW (1992): Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects. Am J Psychiatr 149:1168-1175
21. Golden RN, Hsiao JK, Lane E, Ekstrom D, Rogers S, Hicks R, Potter WZ (1990): Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients. Psychiatr Res 31:39-47
22. Golden RN, Hsiao J, Lane E, Hicks R, Rogers S, Potter WZ (1989): The effects of intravenous clomipramine on neurohormones in normal subjects. J Clin Endocrinol Metab 68:632-637
23. Golden RN, Gilmore JH, Carson SW (1991): Antidepressant challenge tests: The interface of pharmacokinetics and pharmacodynamics. Psychopharm Bull 27:611-617
24. Hall H, Ogren SO (1981): Effects of antidepressant drugs on different receptors in the brain. Eur J Pharmacol 70:393-407
25. Hollander E, Stein DJ, De Caria CM, Cohen L, Saoud JB, Skodol AE, Kellman D, Rosnick L, Oldham JM (1994): Serotonergic sensitivity in borderline personality disorder: Preliminary findings. Am J Psychiatr 151:277-280
26. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994): International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
27. Hyttel J (1982): Citalopram - Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiatr 6:277-295
28. Hyttel J, Bøgesø KP, Perregaard J, Sánchez C (1992): The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer. J Neural Transm 88:157-160
29. Itil TM, Menon GN, Bozak MM, Itil KZ (1984): CNS effects of citalopram, a new serotonin inhibitor antidepressant (a quantitative pharmacoelectroencephalography study). Prog Neuro-Psychopharmacol Biol Psychiatr 8:397-409
30. Jarrett DB, Pollock B, Miewald JM, Kupfer DJ (1991): Acute effect of intravenous clomipramine upon sleep-related hormone secretion in depressed outpatients and healthy control subjects. Biol Psychiatr 29:3-14
31. Jørgensen H, Knigge U, Warberg J (1992): Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan. Neuroendocrinology 55:336-343
32. Kahn RS, Wetzler S, Asnis GM, Papolos D, Van Praag HM (1990): Serotonin receptor sensitivity in major depression. Biol Psychiatr 28:358-362
33. Kahn RS, Trestman R, Lawlor BA, Gabriel S, Davidson M, Siever L (1994): Effects of ipsapirone in healthy subjects: A dose-response study. Psychopharmacology 114: 155-160
34. Kellar KJ, Hulihan-Giblin BA, Mulroney SE, Lumpkin MD, Flores CM (1992): Stimulation of serotonin 1A receptors increases release of prolactin in the rat. Neuropharmacology 31:643-647
35. Kragh-Sørensen P, Fredricson Overø K, Petersen OL, Jensen K, Parnas W (1981): The kinetics of citalopram: Single and multiple dose studies in man. Acta Pharmacol Toxicol 48:53-60
36. Laakmann G, Chuang I, Gugath M, Ortner M, Schmauss M, Wittman M (1983): Prolactin and antidepressants. In Tolis G, (ed), Prolactin and Prolactinomas, New York, Raven, pp 151-161
37. Laakmann G, Gugath G, Kuss HJ, Zygan K (1984): Comparison of growth hormone and prolactin stimulation induced by chlorimipramine and desimipramine in man in connection with chlorimipramine metabolism. Psychopharmacology 82:62-67
38. Lader M, Melhuish A, Frcka G, Fredricson Overø K, Christensen V (1986): The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. Eur J Clin Pharmacol 31:183-190
39. Lesch KP, Rupprecht R, Poten B, Müller U, Söhnle K, Fritze J, Schulte HM (1989): Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans. Biol Psychiatr 26:203-205
40. Lesch KP, Mayer S, Disselkamp-Tietze J, Hoh A, Schoellnhammer G, Schulte HM (1990): Subsensitivity of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci 46:1271-1277
41. Lesch KP, Hoh A, Schulte HM, Osterheider M, Müller T (1991): Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology 105:415-420
42. Levy AD, Li Q, Rittenhouse PA, Van de Kar LD (1993): Investigation of the role of 5-HT3 receptors in the secretion of prolactin, ACTH and renin. Neuroendocrinology 58:65-70
43. Linkowski P, Kerkhofs M, Van Onderbergen A, Hubain P, Copinschi G, L'Hermite-Balériaux M, Leclercq R, Brasseur M, Mendlewicz J, Van Cauter E (1994): The 24-hour profiles of cortisol, prolactin and growth hormone secretion in mania. Arch Gen Psychiatr 51:616-624
44. Maclndoe JH, Turkington RW (1973): Stimulation of human prolactin secretion by intravenous L-tryptophan. J Clin Invest 52:1972-1978
45. Maes M, Meltzer HY (1995): The serotonin hypothesis of major depression. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress, New York, Raven, pp 933-944
46. McCance SL, Cowen PJ, Waller H, Grahame-Smith DG (1988): The effect of metergoline on endocrine responses to L-tryptophan. J Psychopharmacol 2:90-94
47. Meltzer HY, Maes M (1994a): Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man. Psychopharmacology 114:635-643
48. Meltzer HY, Maes M (1994b): Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects. Biol Psychiatr 35:316-323
49. Meltzer, HY, Maes M (1995): Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatr 38:450-457
50. Meltzer HY, Simonovic M, Sturgeon RD, Fang VS (1981): Effect of antidepressants, lithium and electroconvulsive treatment on rat serum prolactin levels. Acta Psychiatr Scand 63:100-121
51. Meltzer HY, Umberkoman-Wiita B, Robertson A, Tricou BJ, Lowy M, Perline R (1984): Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders: I. Enhanced response in depression and mania. Arch Gen Psychiatr 41:366-374
52. Milne RJ, Goa KL (1991): Citalopram: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs 41:450-477
53. Minamitani N, Minamitani T, Lechan RM, Bolliger-Gruber J, Reichlin S (1987): Paraventricular nucleus mediates prolactin secretory responses to restraint stress, ether stress, and 5-hydroxy-L-tryptophan injection in the rat. Endocrinology 120:860-867
54. Mueller EA, Murphy DL, Sunderland T (1986): Further studies of the putative serotonin receptor mediated mechanism of action in humans. Psychopharmacology 89:388-391
55. Nicholson AN, Pascoe PA (1988): Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor. Neuropharmacology 27:597-602
56. Power AC, Cowen PJ (1992): Neuroendocrine challenge tests: Assessment of 5-HT function in anxiety and depression. Mol Asp Med 13:205-220
57. Price LH, Charney DS, Delgado PL, Goodman WK, Krystal JH, Woods SW, Heninger GR (1990): Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs. J Clin Psychiatr 51(Suppl 4):44-50
58. Rammseyer T, Netter P (1988): Effects of changes in brain 5-HT activity on indicators of cortical arousal. Psychopharmacology 3:231-237
59. Reymond P, Amey M, Souche A, Lambert S, Konrat H, Eap CB, Baumann P (1993): Determination of plasma levels of citalopram and its demethylated and deaminated metabolites by gas chromatography and gas chromatography-mass spectrometry. J Chromatograph 616:221-228
60. Rochat B, Amey M, Baumann P (1995): Analysis of the enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reversephase liquid chromatography. Ther Drug Monit 17:273-279
61. Ross SB (1991): Heterogenous binding of sigma radioligands in the rat brain and liver: Possible relationship to subforms of cytochrome P-450. Pharmacol Toxicol 68:293-301
62. Salomon RM, Delgado PL, Licinio J, Krystal JH, Heninger GR, Charney DS (1994): Effects of sleep deprivation on serotonin function in depression. Biol Psychiatr 36:840-846
63. Seifritz E, Hemmeter U, Trachsel L, Lauer CJ, Hatzinger M, Emrich HM, Holsboer F, Holsboer-Trachsler E (1995): Effects of flumazenil on recovery sleep and hormonal secretion after sleep deprivation in male controls. Psychopharmacology 120:449-456
64. 1A receptor activation by flesinoxan in humans: Body temperature and neuroendocrine responses. Neuropsychopharmacology 13:93-104
65. Smith CE, Ware CJ, Cowen PJ (1991): Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan. Psychopharmacology 103:140-142
66. Steiger A, Herth T, Holsboer F (1987): Sleep-electroencephalography and the secretion of cortisol and growth hormone in normal controls. Acta Endocrinol (Copenh) 116:36-42
67. Tuomisto J, Männistö P (1985): Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 37:249-332
68. Van Cauter E, Refetoff S (1985): Multifactorial control of the 24-hour secretory profiles of pituitary hormones. J Endocrinol Invest 8:381-391
69. Van de Kar LD (1991): Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Ann Rev Pharmacol Toxicol 31:289-320
70. Van de Kar LD, Bethea CL (1982): Pharmacological evidence that serotonergic stimulation of prolactic secretion is mediated via the dorsal raphe nucleus. Neuroendocrinology 35:225-230
71. Van de Kar LD, Urban JH, Richardson KD, Bethea CL (1985): Pharmacological studies on the serotoninergic and non-serotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Neuroendocrinology 41:283-288
72. Van Praag HM, Lemus C, Kahn R (1987): Hormonal probes of central serotonergic activity: Do they really exist? Biol Psychiatr 22:86-98
73. Wesemann W, Rotsch M, Schulz E, Sturm D, Zöfel P (1986a): Circadian rhythm of serotonin binding in rat brain: I. Effect of the light-dark cycle. Chronobiol Int 3:135-139
74. Wesemann W, Rotsch M, Schulz E, Zöfel P (1986b): Circadian rhythm of serotonin binding in rat brain: II. Influence of sleep deprivation and imipramine. Chronobiol Int 3: 141-146
75. 2-like receptors by amisulpiride: Effects on hormone secretion in healthy volunteers. J Psychiatr Res 28:461-473
76. Wirz-Justice A (1987): Circadian rhythms in mammalian neurotransmitter receptors. Prog Neurobiol 29:219-259